You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • LUPUS-BEST—treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial

Article info

Article menu

Download PDFPDF

XML
Protocol
LUPUS-BEST—treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial

Authors

  • Johanna Mucke Policlinic and Hiller Research Unit for Rheumatology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany PubMed articlesGoogle scholar articles
  • Oliver Kuss German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Dusseldorf, GermanyCentre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Dusseldorf, Germany PubMed articlesGoogle scholar articles
  • Ralph Brinks Policlinic and Hiller Research Unit for Rheumatology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, GermanyChair for Medical Biometry and Epidemiology, Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany PubMed articlesGoogle scholar articles
  • Sabine Schanze German Lupus Self-Help Community, Wuppertal, Germany PubMed articlesGoogle scholar articles
  • Matthias Schneider Policlinic and Hiller Research Unit for Rheumatology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Johanna Mucke; johanna.mucke{at}med.uni-duesseldorf.de
View Full Text

Citation

Mucke J, Kuss O, Brinks R, et al
LUPUS-BEST—treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial
Lupus Science & Medicine 2021;8:e000516. doi: 10.1136/lupus-2021-000516

Publication history

  • Received May 1, 2021
  • Accepted June 26, 2021
  • First published July 12, 2021.
Online issue publication 
July 12, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.